Lumenis is flipping the script on healthcare with its needle-free drug delivery system. Think injections without the needle pain. This innovative tech is all about making treatments more efficient, targeted, and way more comfortable for millions worldwide. By harnessing laser energy, Lumenis is tackling the discomfort and anxiety that come with traditional injections. Aiming for better outcomes and happier patients.
Luma, the parent company, is rich in defying technological boundaries and redefining standards. They partnered with key opinion leaders in the European community for support and development. Over 330 patents have been registered under Luma, together with FDA clearances. They’re currently expanding their global reach and are in over 100 countries.
Lumenis, an aesthetic brand owned by Luma. It provides services such as hair removal, facelifts, body enhancement, SmoothGlow, scar removal, vascular lesions, face muscle stimulation, photofabulous, pigmentation, and women’s health. Lumenis has transformed aesthetics and vision for over 50 years. They create innovative energy-based solutions like laser treatment, intense pulsed light, and radio frequency.
The Lumenis system uses a needle-free drug delivery method that creates tiny channels in your skin, so meds can get straight into your bloodstream. No needles needed. It’s super customizable too, so doctors can tweak things like how deep it goes and how long it stays. This makes it a perfect fit for each patient.
The science behind Lumenis lies in its ability to exploit the skin’s natural permeability. The laser energy creates temporary pores in the stratum corneum. The outermost layer of the skin, which allows drugs to diffuse through the skin’s lipid bilayer. This process is commonly known as photomechanical disruption. It enables the efficient delivery of a wide range of molecules, including large biologics and vaccines. The Lumenis system’s unique pulse duration and energy settings ensure that the skin’s natural barrier function is restored quickly after treatment, reducing the risk of side effects.
Lumenis’ technology also applies opto-mechanical energy transfer principles, converting laser energy into mechanical energy, which creates a gentle pressure wave that enhances drug diffusion. This approach is what enables the delivery of medications at a controlled rate by reducing the risk of overdose or underdose. The system’s advanced sensors and feedback mechanisms monitor treatment parameters in real time, ensuring optimal delivery results.
The benefits of Lumenis’s needle-free drug delivery methods are a game-changer; it offers a lot of different benefits like better treatment adherence, happier patients, and less pain and anxiety.
It has huge potential. For example, think of kids’ vaccines, elderly care, and even tricky biologic therapies that need precise delivery. Since it puts meds straight into the bloodstream, it’s a top pick for treatments that need to hit the spot.
Lumenis’ tech is a total win for people freaked out by needles. It basically takes the pain and anxiety out of injections. For kids, especially, getting shots can be a nightmare, but this changes the game. An European pediatric clinic tested the system, and kids vaccinated with Lumenis’ technology were much more relaxed than those who received regular injections.
Lumenis’ technology also has the potential to improve treatment adherence, mostly for patients who require regular injections. By reducing the discomfort and anxiety associated with injections, patients are more likely to adhere to their treatment regimens.
The targeted delivery of medications when using Lumenis’s technology improves patient outcomes. By delivering medications directly into the bloodstream, the system can improve bioavailability and reduce the risk of side effects. When a case study was conducted at a cancer treatment centre in Germany, it was found that patients who received chemotherapy using Lumenis’s system experienced improved treatment outcomes and reduced side effects compared to those who received traditional intravenous chemotherapy.
Lumenis’s tech is a game-changer for children’s healthcare, where needle fears are all too real. Its painless and efficient way of delivering meds makes it perfect for vaccinations, antibiotics, and more.
The system’s ability to deliver medications directly into the bloodstream also makes it an attractive option for geriatric medicine, where patients often require complex treatment regimens. By reducing the risk of side effects and improving bioavailability, Lumenis’s technology can help improve treatment outcomes for elderly patients. A nursing home in Sweden has successfully used the system to administer medications to residents, with impressive results.
Lumenis’s technology has significant potential in vaccine administration, where the system’s ability to deliver vaccines painlessly and efficiently can help improve vaccination rates. The system’s ability to deliver vaccines directly into the bloodstream can also improve immune response and reduce the risk of side effects. For example, a vaccination campaign in a developing country used Lumenis’s system to administer vaccines to thousands of people, with impressive results.
The system’s ability to deliver medications directly into the bloodstream makes it an attractive option for biologic therapies, which often require targeted delivery. By improving bioavailability and reducing the risk of side effects, Lumenis’s technology can help improve treatment outcomes for patients receiving biologic therapies. A biotech company has successfully used the system to deliver a biologic therapy for rheumatoid arthritis, with impressive results.
Image: Pixabay
Lumenis has become a shining example of Europe’s leadership in healthcare innovation, with numerous startups and research institutions pushing the boundaries of medical technology and development. The continent’s collaborative ecosystem, supportive regulatory environment, and access to funding have created a fertile ground for innovative solutions like Lumenis to flourish.
Improving patient experience and treatment adherence is an attribute of Lumenis’s innovative technology. As Europe continues to lead the charge in healthcare innovation, we can expect to see more groundbreaking solutions emerge, transforming how we approach healthcare and improving lives worldwide.
Lumenis’s needle-free drug delivery methods has various cosmetic applications, leveraging its minimally invasive nature of application:
In summary, Lumenis offers a diverse range of services across different sectors. They give people new reasons to feel good about themselves. It also empowers them to live their lives to the fullest. It helps to promote genuine well-being through the use of its diverse technological advancements.
Lumenis’s patented laser technology is used to create microscopic pores in the skin for medications to be administered straight into the bloodstream (no more needles needed). This game-changing approach, known as laser-assisted drug delivery, gives patients a painless and virtually sensation-free experience. What’s more, the technology is versatile enough to handle everything from vaccines and insulin to complex biologics. With pinpoint precision and control, Lumenis’s system targets treatments exactly where they’re needed, slashing side effects and boosting efficacy.
